新闻

Trendlines: Portfolio Company IBI Ag Leverages AI-Driven System For Development Of De Novo Protein Design Platform For Bioinsecticides.

13 Mar 2026 09:47

Cutting-edge AI technology and proprietary biological data for discovery and validation of these new bioinsecticide proteins pave the way for significant expansion of IBI Ag's development pipeline...

Attachments:

• IBI_Ag_PR_final.pdf

Source: ShareInvestor Express